{"pmid":32398296,"title":"Arterial hypertension and the risk of severity and mortality of COVID-19.","text":["Arterial hypertension and the risk of severity and mortality of COVID-19.","Eur Respir J","Leiva Sisnieguez, C E","Espeche, W G","Salazar, M R","32398296"],"journal":"Eur Respir J","authors":["Leiva Sisnieguez, C E","Espeche, W G","Salazar, M R"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32398296","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1183/13993003.01148-2020","topics":["Treatment"],"weight":1,"_version_":1666714494754095104,"score":9.490897,"similar":[{"pmid":32426113,"pmcid":"PMC7219006","title":"Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?","text":["Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?","Pulm Circ","Horn, Evelyn M","Chakinala, Murali","Oudiz, Ronald","Joseloff, Elizabeth","Rosenzweig, Erika B","32426113"],"journal":"Pulm Circ","authors":["Horn, Evelyn M","Chakinala, Murali","Oudiz, Ronald","Joseloff, Elizabeth","Rosenzweig, Erika B"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426113","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/2045894020922799","topics":["Treatment"],"weight":1,"_version_":1667252837946490881,"score":50.875202},{"pmid":32381262,"pmcid":"PMC7183951","title":"Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission.","text":["Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission.","Br J Anaesth","Roncon, Loris","Zuin, Marco","Zuliani, Giovanni","Rigatelli, Gianluca","32381262"],"journal":"Br J Anaesth","authors":["Roncon, Loris","Zuin, Marco","Zuliani, Giovanni","Rigatelli, Gianluca"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32381262","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.bja.2020.04.056","keywords":["covid-19","icu","comorbidities","hypertension","management"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666419683261153280,"score":45.435383},{"pmid":32489645,"pmcid":"PMC7238818","title":"Letter to the Editor regarding \"Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?\"","text":["Letter to the Editor regarding \"Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?\"","Pulm Circ","Fernandes, Timothy M","Papamatheakis, Demosthenes G","Poch, David S","Kim, Nick H","32489645"],"journal":"Pulm Circ","authors":["Fernandes, Timothy M","Papamatheakis, Demosthenes G","Poch, David S","Kim, Nick H"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489645","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/2045894020925761","weight":0,"_version_":1668623433698639872,"score":43.193356},{"pmid":32339251,"title":"Hypertension is a clinically important risk factor for severe illness and mortality in COVID-19.","text":["Hypertension is a clinically important risk factor for severe illness and mortality in COVID-19.","The virus responsible for COVID-19 binds to the angiotensin converting enzyme-2 (ACE-2) receptor [1]. Several articles have noted that hypertension is a risk factor for COVID-19 [2-7]. It is currently difficult to distinguish between hypertension as an independent risk factor in COVID-19 from one that co-varies with other patient factors such as age and cardiovascular disease. It is difficult from individual reports to determine whether hypertension is a risk factor for development of symptomatic disease or hospitalisation or for more severe disease. Reviewing the literature that reports rates of hypertension amongst included patients indicates a consistent association with more severe disease and increased mortality.","Anaesthesia","Cook, T M","32339251"],"abstract":["The virus responsible for COVID-19 binds to the angiotensin converting enzyme-2 (ACE-2) receptor [1]. Several articles have noted that hypertension is a risk factor for COVID-19 [2-7]. It is currently difficult to distinguish between hypertension as an independent risk factor in COVID-19 from one that co-varies with other patient factors such as age and cardiovascular disease. It is difficult from individual reports to determine whether hypertension is a risk factor for development of symptomatic disease or hospitalisation or for more severe disease. Reviewing the literature that reports rates of hypertension amongst included patients indicates a consistent association with more severe disease and increased mortality."],"journal":"Anaesthesia","authors":["Cook, T M"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339251","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/anae.15103","topics":["Treatment"],"weight":1,"_version_":1666138494267817986,"score":40.88366}]}